# Impilo Healthcare AB — Form D

Impilo Healthcare AB of STOCKHOLM, V7, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-01-07. $69.8M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2025-01-07
- Form: D
- Accession: 0001315863-25-000011
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $69.8M
- Investors: 4
- Date of first sale: 2024-12-23
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-534491

## Issuer

- Name: Impilo Healthcare AB
- CIK: 0002051003
- Entity type: Other
- Jurisdiction: SWEDEN
- Incorporated: 2024
- Address: BOX 3296, STOCKHOLM, V7, 103 65
- Phone: 46 76 115 10 69

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Magnus Carl Edlund | Executive Officer | Stockholm, V7 |
| Jesper Anders Erik Eliasson | Executive Officer | Stockholm, V7 |
| Martin Erik Fagerlund | Executive Officer | Stockholm, V7 |
| Nicholas Erik Hooge | Executive Officer | Stockholm, V7 |
| Fredrik Johan Stromholm | Executive Officer | Stockholm, V7 |

## More

- [CIK 2051003 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2051003&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001315863-25-000011.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.